Susan Hasty, Publisher
Table of Contents . . . August 8th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Endocrinology - Insulin resistance triggers hepatitis C-related liver steatosis and fibrosis
Hepatitis B Virus - Occult hepatitis B may hamper interferon in hepatitis C coinfected patients
Hepatitis C Therapy - Short courses of peginterferon clear hepatitis C genotypes 2 or 3
Rheumatology - Hepatitis C virus infection is not a cause of fibromyalgia
Transplant Medicine - Combination therapy is problematic after hepatitis C-related liver transplants
Allergy & Immunology - Innate immunity overwhelms adenoviral gene expression in the liver
Avian Influenza - International health entity stresses threat from Avian influenza has not ebbed
Awards - Virus research funded at Robarts by U.S.-based Howard Hughes Medical Institute
Business & Finance - Biopharma company announced financial results
Business & Finance - Medical company signs financing agreement with U.S. based investment fund
Cancer Treatment - Novel intrahepatic arterial chemotherapy introduced for hepatocellular carcinoma
Chronic Liver Disease - Liver iron overload in alcoholic end-stage liver disease affects other organs
Complementary & Alternative Medicine - The garlic component allicin prevents immune-mediated liver injury in mice
Diagnostics - Hepatitis C virus serotyping is useful for screening hemodialysis patients
Diagnostics - In situ hybridization can't detect hepatitis C RNA in all liver tissue samples
Diet and Nutrition - Peripheral blood antioxidants change as chronic hepatitis C activity increases
Disease Associations - HIV/HCV co-infection associated with diabetes
Drug Development - Enrollment complete in phase III DIRECT trial evaluating Infergen plus ribavirin
Fatty Liver Disease - Immune response to lipid peroxidation products predicts fibrosis progression
Fatty Liver Disease - Palmitic acid makes rodent liver cells self-destruct
Gastroenterology - Orocecal transit time is longer in non-alcoholic fatty liver disease patients
Hematology - FVII genes account for prothrombin prolongation in liver disease patients
Hematology - Suppressed hematopoiesis is persistent in chronic hepatitis C patients
Hepatic Cancer - Psychological request from patients for hemangioma surgery should be ignored
Hepatitis A - Universal immunization of toddlers in Israel reduces hepatitis A rates
Hepatitis B Prevention - Hepatitis B vaccine doses protect patients regardless of dialysis type
Hepatitis B Virus - Fulminant hepatitis strikes hepatitis B carriers with acute liver disease
Hepatitis B Virus - Hepatitis B basal core-promoter mutants stimulate cirrhosis and cancer
Hepatitis B Virus - Patients with chronic hepatitis B produce high levels of T cell activator
Hepatitis B Virus - Pro-inflammatory cytokine sustains liver injury in chronic hepatitis B
Hepatitis B Virus - Viremia fluctuates in chronic hepatitis B carriers
Hepatitis C - Pharma company provides update on hepatitis C virus R&D pipeline
Hepatitis C Virus - Agreement signed for celgosivir hepatitis C drug in phase 2 clinical development
Hepatitis C Virus - Interferons use IRES-dependent mechanisms to block hepatitis C replication
Hepatitis E Epidemiology - Hepatitis E infection produces unexplained acute hepatitis cases
Hepatocellular Cancer - Multi-step, incremental expansion method for radio frequency ablation examined
Hepatocellular Cancer - Treatment for hepatocellular carcinoma discussed
Liver Cancer - Expression of Wnt antagonists elevated in hepatoblastomas
Liver Cancer - Potential "weak link" between virus and liver cancer discovered
Liver Failure - Type and extent of hepatectomy drives post-surgical complications
Patents - U.K. patents granted covering siRNAs targeting VEGF and HCV
Patents - U.S. patent granted for interferons for treating hepatitis C, viral diseases
Vaccine Development - Pharma company receives grant to develop thermostable vaccines
Vaccine Development - U of Saskatchewan offered $5.6 million for research into vaccines for newborns
Veno-Occlusive Disease - C282Y allele is risk factor for hepatic veno-occlusive disease after HSCT
Virology - HIV values remain stable in hepatitis C coinfected patients on peginterferon
Virology - Hepatitis B virus genotype drives interferon efficacy
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.